Cargando…

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants

Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo–electron microscopy structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yongfei, Zhang, Jun, Xiao, Tianshu, Lavine, Christy L., Rawson, Shaun, Peng, Hanqin, Zhu, Haisun, Anand, Krishna, Tong, Pei, Gautam, Avneesh, Lu, Shen, Sterling, Sarah M., Walsh, Richard M., Rits-Volloch, Sophia, Lu, Jianming, Wesemann, Duane R., Yang, Wei, Seaman, Michael S., Chen, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245151/
https://www.ncbi.nlm.nih.gov/pubmed/34168070
http://dx.doi.org/10.1126/science.abi9745
_version_ 1784738685611147264
author Cai, Yongfei
Zhang, Jun
Xiao, Tianshu
Lavine, Christy L.
Rawson, Shaun
Peng, Hanqin
Zhu, Haisun
Anand, Krishna
Tong, Pei
Gautam, Avneesh
Lu, Shen
Sterling, Sarah M.
Walsh, Richard M.
Rits-Volloch, Sophia
Lu, Jianming
Wesemann, Duane R.
Yang, Wei
Seaman, Michael S.
Chen, Bing
author_facet Cai, Yongfei
Zhang, Jun
Xiao, Tianshu
Lavine, Christy L.
Rawson, Shaun
Peng, Hanqin
Zhu, Haisun
Anand, Krishna
Tong, Pei
Gautam, Avneesh
Lu, Shen
Sterling, Sarah M.
Walsh, Richard M.
Rits-Volloch, Sophia
Lu, Jianming
Wesemann, Duane R.
Yang, Wei
Seaman, Michael S.
Chen, Bing
author_sort Cai, Yongfei
collection PubMed
description Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo–electron microscopy structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase both the accessibility of its receptor binding domain and the binding affinity for receptor angiotensin-converting enzyme 2 (ACE2). The enhanced receptor engagement may account for the increased transmissibility. The B.1.351 variant has evolved to reshape antigenic surfaces of the major neutralizing sites on the S protein, making it resistant to some potent neutralizing antibodies. These findings provide structural details on how SARS-CoV-2 has evolved to enhance viral fitness and immune evasion.
format Online
Article
Text
id pubmed-9245151
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-92451512022-07-08 Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants Cai, Yongfei Zhang, Jun Xiao, Tianshu Lavine, Christy L. Rawson, Shaun Peng, Hanqin Zhu, Haisun Anand, Krishna Tong, Pei Gautam, Avneesh Lu, Shen Sterling, Sarah M. Walsh, Richard M. Rits-Volloch, Sophia Lu, Jianming Wesemann, Duane R. Yang, Wei Seaman, Michael S. Chen, Bing Science Research Articles Several fast-spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have become the dominant circulating strains in the COVID-19 pandemic. We report here cryo–electron microscopy structures of the full-length spike (S) trimers of the B.1.1.7 and B.1.351 variants, as well as their biochemical and antigenic properties. Amino acid substitutions in the B.1.1.7 protein increase both the accessibility of its receptor binding domain and the binding affinity for receptor angiotensin-converting enzyme 2 (ACE2). The enhanced receptor engagement may account for the increased transmissibility. The B.1.351 variant has evolved to reshape antigenic surfaces of the major neutralizing sites on the S protein, making it resistant to some potent neutralizing antibodies. These findings provide structural details on how SARS-CoV-2 has evolved to enhance viral fitness and immune evasion. American Association for the Advancement of Science 2021-08-06 2021-06-24 /pmc/articles/PMC9245151/ /pubmed/34168070 http://dx.doi.org/10.1126/science.abi9745 Text en Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY). https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Cai, Yongfei
Zhang, Jun
Xiao, Tianshu
Lavine, Christy L.
Rawson, Shaun
Peng, Hanqin
Zhu, Haisun
Anand, Krishna
Tong, Pei
Gautam, Avneesh
Lu, Shen
Sterling, Sarah M.
Walsh, Richard M.
Rits-Volloch, Sophia
Lu, Jianming
Wesemann, Duane R.
Yang, Wei
Seaman, Michael S.
Chen, Bing
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
title Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
title_full Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
title_fullStr Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
title_full_unstemmed Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
title_short Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
title_sort structural basis for enhanced infectivity and immune evasion of sars-cov-2 variants
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245151/
https://www.ncbi.nlm.nih.gov/pubmed/34168070
http://dx.doi.org/10.1126/science.abi9745
work_keys_str_mv AT caiyongfei structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT zhangjun structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT xiaotianshu structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT lavinechristyl structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT rawsonshaun structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT penghanqin structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT zhuhaisun structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT anandkrishna structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT tongpei structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT gautamavneesh structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT lushen structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT sterlingsarahm structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT walshrichardm structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT ritsvollochsophia structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT lujianming structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT wesemannduaner structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT yangwei structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT seamanmichaels structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants
AT chenbing structuralbasisforenhancedinfectivityandimmuneevasionofsarscov2variants